In vivo biocompatibility and degradability of a novel injectable-chitosan-based implant

Fwu Long Mi, Yu Chiun Tan, Hsiang F. Liang, Hsing W. Sung

研究成果: 雜誌貢獻文章同行評審

500 引文 斯高帕斯(Scopus)


A novel injectable-chitosan-based delivery system with low cytotoxicity was fabricated in the study. The chitosan microspheres with small particle size, low crystallinity and good sphericity were prepared by a spray-drying method followed by treating with a crosslinker. In the study, a naturally occurring crosslinking reagent (genipin), which has been used in herbal medicine and in the production of food dyes, was used to crosslink the chitosan microspheres. The glutaraldehyde-crosslinked counterparts were used as a control. Histological study of the genipin-crosslinked chitosan microspheres injected intramuscularly into the skeletal muscle of a rat model showed a less inflammatory reaction than its glutaraldehyde-crosslinked counterparts. The results of the scanning electron microscopic examination indicated that the glutaraldehyde-crosslinked chitosan microspheres retrieved at 12-week postoperatively were already degraded into a loose and porous structure. However, the degradation of the genipin-crosslinked chitosan microspheres was not significant after 20 weeks of implantation. The results of the study demonstrated that the genipin-crosslinked chitosan microspheres have a superior biocompatibility and a slower degradation rate than the glutaraldehyde-crosslinked chitosan microspheres. Accordingly, the genipin-crosslinked chitosan microspheres may be a suitable polymeric carrier for long-acting injectable drug delivery.

頁(從 - 到)181-191
出版狀態已發佈 - 1月 1 2002

ASJC Scopus subject areas

  • 生物技術
  • 生物工程
  • 生物醫學工程


深入研究「In vivo biocompatibility and degradability of a novel injectable-chitosan-based implant」主題。共同形成了獨特的指紋。